Advertisement
Screener

Sage Therapeutics, Inc. Comprehensive Income

Sage Therapeutics, Inc. Comprehensive Income

Sage Therapeutics, Inc. reported Comprehensive Income of -$49.78 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-30.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-07-30

  • Sage Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$49.78M.
  • Sage Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$62.32M.
  • Sage Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$96.44M.
  • Sage Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$91.96M.
  • Sage Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$399.61M.
  • Sage Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$532.10M.
  • Sage Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$540.33M.
  • Sage Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$460.97M, a 176.17% decline from fiscal 2020.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2025-06-30-$49.78M
10-Q · filed 2025-07-30
-$112.09M
10-Q · filed 2025-07-30
-$208.53M
derived: sum of 3 quarters · filed 2025-07-30
-$300.49M
derived: sum of 4 quarters · filed 2025-07-30
2025-03-31-$62.32M
10-Q · filed 2025-04-29
-$158.75M
derived: sum of 2 quarters · filed 2025-04-29
-$250.71M
derived: sum of 3 quarters · filed 2025-04-29
-$353.47M
derived: sum of 4 quarters · filed 2025-07-30
2024-12-31-$96.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
-$188.39M
derived: sum of 2 quarters · filed 2025-02-11
-$291.15M
derived: sum of 3 quarters · filed 2025-07-30
-$399.61M
10-K · filed 2025-02-11
2024-09-30-$91.96M
10-Q · filed 2024-10-29
-$194.72M
derived: sum of 2 quarters · filed 2025-07-30
-$303.17M
10-Q · filed 2024-10-29
-$332.96M
derived: sum of 4 quarters · filed 2025-07-30
2024-06-30-$102.76M
10-Q · filed 2025-07-30
-$211.21M
10-Q · filed 2025-07-30
-$241.00M
derived: sum of 3 quarters · filed 2025-07-30
-$440.72M
derived: sum of 4 quarters · filed 2025-07-30
2024-03-31-$108.46M
10-Q · filed 2025-04-29
-$138.24M
derived: sum of 2 quarters · filed 2025-04-29
-$337.96M
derived: sum of 3 quarters · filed 2025-04-29
-$498.84M
derived: sum of 4 quarters · filed 2025-04-29
2023-12-31-$29.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
-$229.51M
derived: sum of 2 quarters · filed 2025-02-11
-$390.39M
derived: sum of 3 quarters · filed 2025-02-11
-$532.10M
10-K · filed 2025-02-11
2023-09-30-$199.72M
10-Q · filed 2024-10-29
-$360.60M
derived: sum of 2 quarters · filed 2024-10-29
-$502.31M
10-Q · filed 2024-10-29
-$644.78M
derived: sum of 4 quarters · filed 2025-02-11
2023-06-30-$160.88M
10-Q · filed 2024-07-31
-$302.59M
10-Q · filed 2024-07-31
-$445.06M
derived: sum of 3 quarters · filed 2025-02-11
-$583.39M
derived: sum of 4 quarters · filed 2025-02-11
2023-03-31-$141.71M
10-Q · filed 2024-04-25
-$284.18M
derived: sum of 2 quarters · filed 2025-02-11
-$422.51M
derived: sum of 3 quarters · filed 2025-02-11
-$551.44M
derived: sum of 4 quarters · filed 2025-02-11
2022-12-31-$142.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
-$280.80M
derived: sum of 2 quarters · filed 2025-02-11
-$409.73M
derived: sum of 3 quarters · filed 2025-02-11
-$540.33M
10-K · filed 2025-02-11
2022-09-30-$138.33M
10-Q · filed 2023-11-07
-$267.26M
derived: sum of 2 quarters · filed 2023-11-07
-$397.86M
10-Q · filed 2023-11-07
-$524.93M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30-$128.93M
10-Q · filed 2023-08-07
-$259.53M
10-Q · filed 2023-08-07
-$386.59M
derived: sum of 3 quarters · filed 2024-02-14
-$516.78M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31-$130.60M
10-Q · filed 2023-05-02
-$257.66M
derived: sum of 2 quarters · filed 2024-02-14
-$387.85M
derived: sum of 3 quarters · filed 2024-02-14
-$495.15M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31-$127.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
-$257.26M
derived: sum of 2 quarters · filed 2024-02-14
-$364.55M
derived: sum of 3 quarters · filed 2024-02-14
-$460.97M
10-K · filed 2024-02-14
2021-09-30-$130.19M
10-Q · filed 2022-11-08
-$237.49M
derived: sum of 2 quarters · filed 2022-11-08
-$333.90M
10-Q · filed 2022-11-08
$640.46M
derived: sum of 4 quarters · filed 2023-02-16
2021-06-30-$107.29M
10-Q · filed 2022-08-02
-$203.71M
10-Q · filed 2022-08-02
$770.65M
derived: sum of 3 quarters · filed 2023-02-16
$664.16M
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31-$96.42M
10-Q · filed 2022-05-03
$877.95M
derived: sum of 2 quarters · filed 2023-02-16
$771.45M
derived: sum of 3 quarters · filed 2023-02-16
$637.61M
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31$974.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$867.87M
derived: sum of 2 quarters · filed 2023-02-16
$734.02M
derived: sum of 3 quarters · filed 2023-02-16
$605.19M
10-K · filed 2023-02-16
2020-09-30-$106.50M
10-Q · filed 2021-11-02
-$240.34M
derived: sum of 2 quarters · filed 2021-11-02
-$369.17M
10-Q · filed 2021-11-02
-$538.31M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$133.85M
10-Q · filed 2021-08-03
-$262.67M
10-Q · filed 2021-08-03
-$431.81M
derived: sum of 3 quarters · filed 2022-02-24
-$611.56M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$128.83M
10-Q · filed 2021-05-04
-$297.96M
derived: sum of 2 quarters · filed 2022-02-24
-$477.72M
derived: sum of 3 quarters · filed 2022-02-24
-$644.26M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$169.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$348.89M
derived: sum of 2 quarters · filed 2022-02-24
-$515.43M
derived: sum of 3 quarters · filed 2022-02-24
-$678.43M
10-K · filed 2022-02-24
2019-09-30-$179.76M
10-Q · filed 2020-11-05
-$346.30M
derived: sum of 2 quarters · filed 2020-11-05
-$509.29M
10-Q · filed 2020-11-05
-$667.94M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30-$166.54M
10-Q · filed 2020-08-10
-$329.54M
10-Q · filed 2020-08-10
-$488.18M
derived: sum of 3 quarters · filed 2021-02-24
-$611.21M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31-$163.00M
10-Q · filed 2020-05-07
-$321.64M
derived: sum of 2 quarters · filed 2021-02-24
-$444.67M
derived: sum of 3 quarters · filed 2021-02-24
-$461.61M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31-$158.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
-$281.68M
derived: sum of 2 quarters · filed 2021-02-24
-$298.61M
derived: sum of 3 quarters · filed 2021-02-24
-$373.37M
10-K · filed 2021-02-24
2018-09-30-$123.03M
10-Q · filed 2019-11-12
-$139.97M
derived: sum of 2 quarters · filed 2019-11-12
-$214.72M
10-Q · filed 2019-11-12
-$284.16M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$16.94M
10-Q · filed 2019-08-06
-$91.69M
10-Q · filed 2019-08-06
-$161.13M
derived: sum of 3 quarters · filed 2020-02-27
-$234.79M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$74.75M
10-Q · filed 2019-05-02
-$144.19M
derived: sum of 2 quarters · filed 2020-02-27
-$217.86M
derived: sum of 3 quarters · filed 2020-02-27
-$288.05M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$69.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$143.10M
derived: sum of 2 quarters · filed 2020-02-27
-$213.29M
derived: sum of 3 quarters · filed 2020-02-27
-$270.05M
10-K · filed 2020-02-27
2017-09-30-$73.67M
10-Q · filed 2018-11-06
-$143.85M
derived: sum of 2 quarters · filed 2018-11-06
-$200.61M
10-Q · filed 2018-11-06
-$256.58M
derived: sum of 4 quarters · filed 2019-02-19
2017-06-30-$70.19M
10-Q · filed 2018-08-07
-$126.94M
10-Q · filed 2018-08-07
-$182.91M
derived: sum of 3 quarters · filed 2019-02-19
-$220.78M
derived: sum of 4 quarters · filed 2019-02-19
2017-03-31-$56.76M
10-Q · filed 2018-05-03
-$112.72M
derived: sum of 2 quarters · filed 2019-02-19
-$150.59M
derived: sum of 3 quarters · filed 2019-02-19
-$185.30M
derived: sum of 4 quarters · filed 2019-02-19
2016-12-31-$55.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19
-$93.84M
derived: sum of 2 quarters · filed 2019-02-19
-$128.55M
derived: sum of 3 quarters · filed 2019-02-19
-$159.09M
10-K · filed 2019-02-19
2016-09-30-$37.87M
10-Q · filed 2017-11-02
-$72.58M
derived: sum of 2 quarters · filed 2017-11-02
-$103.12M
10-Q · filed 2017-11-02
-$131.68M
derived: sum of 4 quarters · filed 2018-02-22
2016-06-30-$34.71M
10-Q · filed 2017-08-03
-$65.25M
10-Q · filed 2017-08-03
-$93.81M
derived: sum of 3 quarters · filed 2018-02-22
-$117.85M
derived: sum of 4 quarters · filed 2018-02-22
2016-03-31-$30.54M
10-Q · filed 2017-05-10
-$59.10M
derived: sum of 2 quarters · filed 2018-02-22
-$83.14M
derived: sum of 3 quarters · filed 2018-02-22
-$108.17M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31-$28.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
-$52.60M
derived: sum of 2 quarters · filed 2018-02-22
-$77.62M
derived: sum of 3 quarters · filed 2018-02-22
-$94.50M
10-K · filed 2018-02-22
2015-09-30-$24.04M
10-Q · filed 2016-11-03
-$49.06M
derived: sum of 2 quarters · filed 2016-11-03
-$65.93M
10-Q · filed 2016-11-03
2015-06-30-$25.03M
10-Q · filed 2016-08-09
-$41.90M
10-Q · filed 2016-08-09
2014-12-31-$33.81M
10-K · filed 2017-02-24